Filing Details

Accession Number:
0001127602-20-031074
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-10 16:25:01
Reporting Period:
2020-12-09
Accepted Time:
2020-12-10 16:25:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635424 M Terence Berge C/O Conmed Corporation
525 French Road
Utica NY 13502
Vp-Corporate Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-09 2,870 $100.64 3,042 No 4 S Direct
Common Stock Disposition 2020-12-09 2,038 $101.43 1,004 No 4 S Direct
Common Stock Acquisiton 2020-12-09 5,400 $59.96 6,404 No 4 M Direct
Common Stock Disposition 2020-12-09 4,593 $100.39 1,811 No 4 S Direct
Common Stock Disposition 2020-12-09 807 $101.47 1,004 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2020-12-09 5,400 $0.00 5,400 $59.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,100 2028-03-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.04 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.06 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  5. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.